First Command Advisory Services, Inc. Altimmune, Inc. Transaction History

First Command Advisory Services, Inc.

  • $10.4 Billion
  • Q3 2024

A detailed history of First Command Advisory Services, Inc. transactions in Altimmune, Inc. stock. As of the latest transaction made, First Command Advisory Services, Inc. holds 250 shares of ALT stock, worth $1,715. This represents 0.0% of its overall portfolio holdings.

Number of Shares
250
Previous 250 -0.0%
Holding current value
$1,715
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 26, 2024
BUY
$5.91 - $10.23 $1,477 - $2,557
250 New
250 $1,000

Others Institutions Holding ALT

# of Institutions
186
Shares Held
39.3M
Call Options Held
913K
Put Options Held
743K
View Full List

About Altimmune, Inc.

ALT Quotes by TradingView
  • Ticker ALT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,025,300
  • Market Cap $336M
  • Description
  • Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatit...
More about ALT
Track This Portfolio

Track First Command Advisory Services, Inc. Portfolio

Follow First Command Advisory Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Command Advisory Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Command Advisory Services, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email